iRhythm Holdings (IRTC) Share-based Compensation Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -4.08% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 12.94% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 26.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 59.09% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 31.63% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | -7.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.94% |
| Dec 31, 2025 | 31.85% |
| Sep 30, 2025 | 22.43% |
| Jun 30, 2025 | 4.61% |
| Mar 31, 2025 | 11.21% |
| Dec 31, 2024 | -32.87% |
| Sep 30, 2024 | -18.33% |
| Jun 30, 2024 | 54.77% |
| Mar 31, 2024 | 15.01% |
| Dec 31, 2023 | 50.98% |
| Sep 30, 2023 | 62.29% |
| Jun 30, 2023 | -6.62% |
| Mar 31, 2023 | 31.27% |
| Dec 31, 2022 | 32.99% |
| Sep 30, 2022 | 6.45% |
| Jun 30, 2022 | 47.15% |
| Mar 31, 2022 | -31.28% |
| Dec 31, 2021 | -15.16% |
| Sep 30, 2021 | -30.29% |
| Jun 30, 2021 | 5.04% |
| Mar 31, 2021 | 6,532.79% |
| Dec 31, 2020 | 95.04% |
| Sep 30, 2020 | 135.70% |
| Jun 30, 2020 | 33.26% |
| Mar 31, 2020 | -93.72% |
| Dec 31, 2019 | 49.68% |
| Sep 30, 2019 | 75.75% |
| Jun 30, 2019 | 79.83% |
| Mar 31, 2019 | 49.55% |
| Dec 31, 2018 | 75.77% |
| Sep 30, 2018 | 54.19% |
| Jun 30, 2018 | 79.96% |
| Mar 31, 2018 | 60.11% |
| Dec 31, 2017 | 340.00% |
| Sep 30, 2017 | 581.05% |
| Jun 30, 2017 | 411.29% |
| Mar 31, 2017 | 397.06% |
| Dec 31, 2016 | 65.33% |
| Sep 30, 2016 | 26.10% |